Publications:

Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis.

Cell

Grebien, Florian F; Hantschel, Oliver O; Wojcik, John J; Kaupe, Ines I; Kovacic, Boris B; Wyrzucki, Arkadiusz M AM; Gish, Gerald D GD; Cerny-Reiterer, Sabine S; Koide, Akiko A; Beug, Hartmut H; Pawson, Tony T; Valent, Peter P; Koide, Shohei S; Superti-Furga, Giulio G

Publication Date: 2011-10-14

Variant appearance in text: PI3K: S72K

PubMed Link: 22000011

Variant Present in the following documents:

• Main text
• mmc3.pdf

View BVdb publication page